CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response
Simple Summary
- Supplementary File 1:
ZIP-Document (ZIP, 264 KiB)
de Nonneville, A.; Finetti, P.; Picard, M.; Monneur, A.; Pantaleo, M.A.; Astolfi, A.; Ostrowski, J.; Birnbaum, D.; Mamessier, E.; Bertucci, F. CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response. Cancers 2022, 14, 1306. https://doi.org/10.3390/cancers14051306
de Nonneville A, Finetti P, Picard M, Monneur A, Pantaleo MA, Astolfi A, Ostrowski J, Birnbaum D, Mamessier E, Bertucci F. CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response. Cancers. 2022; 14(5):1306. https://doi.org/10.3390/cancers14051306
Chicago/Turabian Stylede Nonneville, Alexandre, Pascal Finetti, Maelle Picard, Audrey Monneur, Maria A. Pantaleo, Annalisa Astolfi, Jerzy Ostrowski, Daniel Birnbaum, Emilie Mamessier, and François Bertucci. 2022. "CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response" Cancers 14, no. 5: 1306. https://doi.org/10.3390/cancers14051306